医学影像预测肝细胞癌治疗后复发的研究进展

Research Progress of Medical Imaging Predictions of HCC Recurrence after Treatment

肝细胞癌是世界上第六大最常见的癌症,由于其发病率不断上升,它已成为普通人群中癌症相关死亡的第三大原因。尽管肝细胞癌患者的治疗不断改进,但术后复发率仍不断上升。因此,早期诊断肝细胞癌的复发并给予相应的个体化治疗成为目前提高肝细胞癌患者生存率的重点。目前肝癌是唯一无需病理诊断,仅通过影像学手段即可确诊的实体肿瘤。无创的影像学检查方法,在肝癌的诊断、分期、疗效评价及预后等中发挥了重要作用。随着影像学检查的精准化发展,也提升了肝癌患者整体的生存率。该篇综述旨在讨论医学影像预测肝细胞癌治疗后复发的研究进展。Hepatocellular carcinoma is the sixth most common cancer in the world. Because of its rising incidence rate, it has become the third leading cause of cancer-related deaths in the general population. Despite continuous improvement in the treatment of hepatocellular carcinoma patients, the postoperative recurrence rate continues to rise. Therefore, early diagnosis of hepatocellular carcinoma recurrence and corresponding personalized treatment have become the focus of improving the survival rate of hepatocellular carcinoma patients. At present, liver cancer is the only solid tumor that can be diagnosed through imaging methods without pathological diagnosis. The non-invasive imaging examination method has played an important role in the diagnosis, staging, efficacy evaluation, and prognosis of liver cancer. With the development of precise imaging examinations, the overall survival rate of liver cancer patients has also been improved. This review aims to discuss the research progress of medical imaging in predicting the recurrence of hepatocellular carcinoma after treatment.